Tags

Type your tag names separated by a space and hit enter

Recognizing and managing patients with irritable bowel syndrome.

Abstract

PURPOSE

To address the diagnosis and clinical management of irritable bowel syndrome (IBS) and provide a discussion of the available serotonergic agents.

DATA SOURCES

Recent studies examining the pathophysiology of IBS.

CONCLUSIONS

Diagnostic testing may be required in the subset of patients with IBS who present with alarm symptoms, or "red flags," suggestive of underlying organic disease. An important role has been suggested for the neurotransmitter serotonin in both gut motility and visceral pain sensitivity.

IMPLICATIONS FOR PRACTICE

A diagnosis of IBS is largely based on symptoms; therefore, effective clinician-patient communication and careful attention to details of patient presentation, history, and physical examination are essential.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Seattle Gastroenterology Associates, Seattle, Washington, USA. acroghan@u.washington.edu

    Source

    MeSH

    Humans
    Irritable Bowel Syndrome

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    15715899

    Citation

    Croghan, Anne, and Margaret M. Heitkemper. "Recognizing and Managing Patients With Irritable Bowel Syndrome." Journal of the American Academy of Nurse Practitioners, vol. 17, no. 2, 2005, pp. 51-9.
    Croghan A, Heitkemper MM. Recognizing and managing patients with irritable bowel syndrome. J Am Acad Nurse Pract. 2005;17(2):51-9.
    Croghan, A., & Heitkemper, M. M. (2005). Recognizing and managing patients with irritable bowel syndrome. Journal of the American Academy of Nurse Practitioners, 17(2), pp. 51-9.
    Croghan A, Heitkemper MM. Recognizing and Managing Patients With Irritable Bowel Syndrome. J Am Acad Nurse Pract. 2005;17(2):51-9. PubMed PMID: 15715899.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Recognizing and managing patients with irritable bowel syndrome. AU - Croghan,Anne, AU - Heitkemper,Margaret M, PY - 2005/2/18/pubmed PY - 2005/6/23/medline PY - 2005/2/18/entrez SP - 51 EP - 9 JF - Journal of the American Academy of Nurse Practitioners JO - J Am Acad Nurse Pract VL - 17 IS - 2 N2 - PURPOSE: To address the diagnosis and clinical management of irritable bowel syndrome (IBS) and provide a discussion of the available serotonergic agents. DATA SOURCES: Recent studies examining the pathophysiology of IBS. CONCLUSIONS: Diagnostic testing may be required in the subset of patients with IBS who present with alarm symptoms, or "red flags," suggestive of underlying organic disease. An important role has been suggested for the neurotransmitter serotonin in both gut motility and visceral pain sensitivity. IMPLICATIONS FOR PRACTICE: A diagnosis of IBS is largely based on symptoms; therefore, effective clinician-patient communication and careful attention to details of patient presentation, history, and physical examination are essential. SN - 1041-2972 UR - https://www.unboundmedicine.com/medline/citation/15715899/Recognizing_and_managing_patients_with_irritable_bowel_syndrome_ L2 - https://doi.org/10.111/j.1041-2972.2005.0011.x DB - PRIME DP - Unbound Medicine ER -